
    
      The investigators will track patients in the first and second cycles of chemotherapy.
      Information regarding comorbidities, medical history and sociodemographic characteristics
      will be collected. The impact of nausea and vomiting induced by the treatment on patient's
      quality of life will be evaluated using the questionnaire Functional Living Index-Emesis -
      FLIE.
    
  